Fitness watches generate useful information, but increase patient anxiety

 

Copenhagen, Denmark (August 4, 2020) — How does measuring our sleep, exercise and heart rates using various apps and fitness watches affect us? Self-quantifying may better the understanding of our individual health, but according to a new study, it also gives rise to anxiety.

Is my heart beating slightly fast? Is a heart attack coming? I didn’t sleep as much as I thought I had last night – is that bad for my heart?

Health apps and fitness watches can shed considerable light on how our bodies work and make recommendations for a healthy lifestyle.

However, self-measuring can have a downside too, according to a new study that examined the experiences of 27 heart patients who used ‚Fitbit‘ fitness watches to measure their sleep, heart rates and physical activity.

Although the 28-74 year-old heart patients learned more about their illnesses and were motivated to exercise during the six months that they wore the watches, they also became more anxious, explains Tariq Osman Andersen, an assistant professor at the University of Copenhagen’s Department of Computer Science and one of the researchers behind the study:

„Our study shows that, overall, self-measurements are more problematic than beneficial when it comes to the patient experience. Patients begin to use the information from their Fitbits just as they would use a doctor. However, they don’t get help interpreting their watch data. This makes them unnecessarily anxious, or they may learn something that is far from reality,“ he says.

 

Generates insecurity and anxiousness

Along with two other researchers from the University of Copenhagen and the company Vital Beats, Tariq Osman Andersen examined patients with cardiac arrhythmia and pacemakers through 66 qualitative interviews.

They conclude that, overall, there are two points that include both the pros and cons of using Fitbit watches:

 

– More information calms, but also awakens doubt

Patients have a sense that they are becoming more in tune with their overall health, but they link the information to their heart disease, for which there is no safe basis. For example, if they see that they aren’t sleeping as much as they should be, they become uncomfortable and fear that this may exacerbate their illness. Similarly, they often link fast hearts rate with an increased risk of heart attack.

„Conversely, the Fitbit watch can be calming, if data shows that you are sleeping well and have a low heart rate. The problem is that you cannot use data directly related to heart disease because the watch is designed for sports and wellness, as opposed to managing disease,“ explains Tariq Osman Andersen.

Patients gain the courage to exercise, while simultaneously experiencing feelings of guilt

Another aspect of the Fitbit watch with both positive and negative aspects, is exercise. On one hand, patients were motivated to be active, but at the same time, the app revealed when patients did not attain the recommended 10,000 daily steps, which made many of them feel guilty.

„The Fitbit watch is not designed for heart patients, so they should not necessarily follow the same recommendations for exercise as those who are in good health,“ explains Tariq Osman Andersen.

 

– Help needed for interpretation

The use of health apps like the Fitbit watch is part of a growing trend to measure the health of, among others, those with chronic illnesses. According to Tariq Osman Andersen, they offer great promise:

„There is a tremendous potential in engaging patients outside the hospital by allowing them to manage their illnesses through health apps like the Fitbit watch,“ he explains.

But for health apps to have an effect, patients need help interpreting data related to sleep, heart rate and exercise habits, according to the research team behind the study:

„We believe it is time to think in terms of ‚collaborative care‘, where both patient and clinicians benefit from the new health data and are thereby able to work together to manage and treat chronic diseases. This requires that we create a digital platform in which clinicians and patients can jointly interpret data from, for example, fitness watches, without creating unnecessary additional work for clinicians,“ concludes Tariq Osman Andersen.

 


University of Copenhagen, 04.08.2020 (tB).

Schlagwörter: ,

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…